Abstract
Background: To investigate the associations between Vaginal Pathogenic Community with Bacterial vaginosis, Candida vaginitis, and Trichomonas vaginalis in Chinese women. Method: In this experiment, ten BV, nine VVC, eight TV patients, and four non-infected healthy women were recruited. The vaginal samples were collected from the vaginal orifice, the middle of the vagina, and vaginal fornix from every participant and conducted with next-generation sequencing (NGS). The NGS was based upon the analysis of bacterial 16S rRNA genes by using the Illumina Miseq system. Results: No significant difference in microbiome community structures was observed for the three sampling sites from the same subject. Compared with the healthy population, patients with BV and TV showed more diverse symptoms and had a lower amount of Lactobacillus but a higher number of BV-related bacteria like Atopobium, Dialister, Sneathia, Mobiluncus, and Prevotella. On the contrary, the species composition of the VVC group is relatively simple, which has a significantly high abundance of Lactobacillus. Eight genera, including Arcanobacterium, Clostridium, Moryella, Mobiluncus, Shuttleworthia, Dialister, Bulleidia, and Megasphaera, were closely correlated with BV. Among vaginal pathogenic bacteria, Anaerococcus, Lysobacter, Mycoplasma, Peptoniphilus, Sneathia, and Prevotella were more common, with higher copy numbers in the TV group. Conclusions: The data outlined the overall structure of vaginal communities, indicating that BV and TV were touching related to a sharp increase in the rich taxonomy and diversity of vaginal microbiota. VVC group presented a lower variety, with a significantly high abundance of Lactobacillus.
Keywords: Bacterial vaginosis, candida vaginitis, diversity, next-generation sequencing 16S rRNA gene (16SrDNA), trichomonas vaginalis, vaginal microbiome
Introduction
The vaginal microbiota, one of the important human-microbial habitats, includes a community of microbes with moderate diversity and has an interaction in the vaginal health, yet their correlation and the role of microbiota in health had been just recently confirmed. Studies have revealed that the microbe disruption results in increased susceptibility to various infectious diseases and adverse pregnancy outcomes [1-4]. 75% of women will undergo vaginitis at least once in their life [5]. Most experts believe that 90% of vaginitis cases are subsequently induced by bacterial vaginosis (BV), Candida vaginitis (VVC), and Trichomonas vaginalis (TV) [6-10]. They affect millions of women every year and are closely correlated with several adverse effects, containing preterm labor and delivery pelvic inflammatory disease [11-13], postabortal endometritis [14], etc., such as Neisseria gonorrhoeae, Chlamydia trachomatis, HPV, HSV-2 and HIV-1 [15-20].
The diagnosis of vaginitis mainly depends on the typical clinical symptoms, signs, and microscopic examination of vaginal discharge. Vaginal microscopy is easy to operate at a low cost. However, in practice, its accuracy is often susceptible to multiple factors, such as technical and subjective issues. In comparison, bacterial culture for the detection of bacteria flora is more accurate. Yet, this method is proven to be time-consuming and expensive, which limits its use in in-vitro diagnostic. Next-generation sequencing (NGS) techniques are the latest development in microbial community determination, which has significant improvement in the efficiency of vaginal microbiota research and achieves the high-throughput analysis of hundreds and thousands of samples with more detailed taxonomic information about the microbes [21-23]. This further our understanding that vaginal microbiota and the longitudinal changes occur in both healthy women and patients with vaginitis [24-26]. In addition, a great many molecular biological techniques based on 16SrDNA gene sequence diversity have been developed to explore the microbial community of the vaginal bacterial ecosystem.
Material and methods
Materials
In this experiment, 10 BV, 9 VVC, 8 TV patients, and 4 non-infected healthy women in the First Affiliated Hospital of Baotou Medical College in China from February to June 2015 were recruited. Ethics Committees of the First Affiliated Hospital of Baotou Medical College authorized the institutional review board approvals for the study. There was no significant difference in general data between the four groups. As shown in Table 1.
Table 1.
The general data of the four groups
| NC group (n=10) | BV group (n=9) | VVC group (n=8) | TV group (n=4) | P | |
|---|---|---|---|---|---|
| Age (x̅ ± s, year) | 32.39±7.20 | 30.19±6.37 | 34.18±8.24 | 35.14±9.03 | 0.629 |
| BMI (x̅ ± s, kg/m2) | 21.97±4.29 | 20.85±4.84 | 22.11±5.25 | 20.36±6.46 | 0.932 |
| Duration (x̅ ± s, month) | 4.67±1.29 | 4.16±1.36 | 4.62±1.82 | 4.48±2.04 | 0.897 |
| Delivery | 0.507 | ||||
| Yes | 8 | 6 | 7 | 4 | |
| No | 2 | 3 | 1 | 0 |
Inclusion and exclusion criteria
Inclusion criteria
1) Patients with vaginitis confirmed by clinical and laboratory pathogenic examination [27,28] before the test; 2) With follow-up conditions, good compliance and signed informed consent of volunteers; 3) 18-50 years of age, sexual life history, menstrual period; 4) Patients who were not treated with any oral medication in the last one month; 5) Patients who were not treated with any external drugs in the last two weeks; 6) The pregnancy test was negative in women of childbearing age, during the test can adhere to contraception and condom use in life.
Exclusion criteria
1) Participants who were under 18 years old or above 55 years old; 2) Participants with pregnancy or diabetes; 3) Participants taking antibiotics or vaginal antimicrobials (orally or topically used to the vulvar/vaginal area) in the previous month; 4) Participants during their period or with menoxenia; 5) Participants with famous active co-infection with Chlamydia and Neisseria gonorrhoeae; 6) Participants with clinically apparent herpes simplex infection.
DNA extraction and MiSeq sequencing of 16S gene amplicons
DNA was purified according to standard methods in the reference [29]. Firstly, we used a NanoDrop Spectrophotometer and agarose gel electrophoresis to examine the DNA density and quality. Next, we diluted DNA extraction to 2 ng/μL and then stored it at -20°C for the use of downstream universal primers 5’-GTACTCCTACGGGAGGCAGCA-3’ and 5’-GTGGACTACHVGGGTWTCTAAT-3’. In addition, 8 nt barcodes were used to amplify the V3V4 hypervariable areas of 16S rRNA genes by MiSeq sequencer [30,31]. The PCR mixture (25 μL) was composed of 1× PCR buffer, 1.5 mM MgCl2, 0.4 μM deoxyribonucleoside triphosphate, 1.0 μM primer, and 1 U of TransStart FastPfu DNA Polymerase (TransGen, China) and 4 ng genomic DNA. The PCR amplification steps are as follows: Firstly, 3 minutes of denaturation is performed at 94°C, next 23 cycles of 94°C for 30 seconds, next cooled to 60°C for 40 seconds, and up to 72°C for 60 seconds, and extension is the last stage when the sample is again subjected to 72°C for 10 minutes. Each sample received three PCR, and then it was combined together after amplifications. Next PCR products were given 1.0% agarose gel electrophoresis, and then we excised and purified the band with a correct size based on Gel Extraction Kit (Omega Bio-Tek, USA) and quantified it with the qubit. And all samples were pooled together with an equal molar amount. Following the instruction of the manufacturer, we prepared the sequencing library with TruSeq DNA Kit. According to the Illumina library preparation protocols, we diluted, denatured, and re-diluted the purified library, and thence mixed it with PhiX, which was equivalent to 30% of the final DNA amount, and next applied to an Illumina Miseq system with the Reagent Kit v3 (600 cycles). Based on the quantitative insights into microbial ecology (QIIME) pipeline [32], the original sequences were to link reads into tags according to the overlapped, then we separated reads in each sample with barcodes and removed low-quality reads. Then we gathered the processed tags and allocated the operational taxonomic units (OTUs) to taxa through matching in the Greengenes database [33].
Results
The quality of sequencing
After filtrating the low-quality reads and removing chimeras, we gained 1,108,830 high-quality reads, with 11,923 reads each sample. 10696 OTU were determined from the 93 samples. After the removal of OTU singletons (the number of the tag to 1 OTU) and chimeric sequence, the OTU number is 4533, and then OTU number of samples after sample dilution was 3030. The sequence length distribution was between 400 bp-440 bp, and their average length was 420 bp after managing the primers.
Microbiome diversity of different groups
At the genus level, these four groups differentiated each other. As shown in Figure 1, a total of 20 species of bacteria were found in different distribution profiles. The BV group not only possessed the most species but also had eight exclusive genera, respectively, Arcanobacterium, Mobiluncus, Clostridium, Moryella, Shuttleworthia, Dialister, Bulleidia, and Megasphaera. Five exclusive species, including Gemella, Parvimonas, Peptoniphilus, Lysobacter, and Mycoplasma, were found in TV group, which is second to BV group. Varibaculum and Bacillus were the two particular species of bacteria in NC group, and Lactobacillus is only one genus of bacteria found in VVC group.
Figure 1.

The distribution of enriched genus.
Discussion
In general, a shift in microbial composition has a crucial effect throughout the progression of urogenital diseases. We have demonstrated that TV, BV, and VVC were correlated with changes in the vaginal microbiota compositions, and most of which were obvious at high taxonomic level (phylum) and even genus level. The composition and relative abundance of the vaginal microbiota by phylum did bot contribute to the etiology of BV, VVC, and TV. However, it exposed the holistic structure of the vaginal microbiota. Among the eight phylum in the vaginal ecosystem, Firmicutes and Actinobacteria comprised most of the vaginal microbiota in four groups, especially more prominent in the VVC group. Proteobacteria takes up a considerable proportion of the population in the healthy group, while Bacteroidetes and TM7 were closely correlated with BV, Tenericutes, Fusobacterlia, and Bacteroidetes were strongly associated with TV. In comparison, Lactobacillus typically shows a predominance in the vaginal microbiome of healthy women, similar to the data from Asian women in America [3,4]. Although longitudinal studies on healthy women have discovered the fluctuations of the vaginal microbiome from a situation where Lactobacillus dominates to another structure, most of the snapshot materials follow the predominant pattern of Lactobacillus [34]. It is the main bacterial communities in the healthy vagina containing lactic acid bacteria that doesn’t surprise us. Because these genera stay at a low vaginal pH via their metabolic activity and thus differ in the colonization resistance that protects from the invasion of obvious pathogens or from the overgrowth and dominance of potentially pathogenic species among the normal microbiota.
BV appears to be a polymicrobial process with interrelated organisms, which can lead to a common outcome though the changing patterns, were not always the same for all samples. In the process of normally developing into BV, the vaginal pathogenic bacteria substitutes the healthy vaginal microbiota bit by bit, which is seen through the decrease in the Lactobacillus spp. and other facultative or anaerobic species [35]. In this study, we also demonstrated that Lactobacillus decreases while the vaginal pathogenic bacteria increases, such as Anaerococcus, Arcanobacterium, Megasphaera, Sneathia, and Prevotella. The tendency of the microbial ecosystem resulted in changes from eubiosis to dysbiosis during the advent of BV. Although previous studies have discovered that Gardnerella vaginalis (belonging to Actinobacteria) was a good marker for BV [36-38], we did not find its presence in the BV samples and only detected it in very low abundance in the non-BV samples. The low detection rate of Gardnerella vaginalis may be attributed to the depth of the Illumina Miseq sequencing. In addition, some studies also discovered this species in subjects who didn’t have BV with a low abundance level [39]. Whether Gardnerella vaginalis is suitable for BV diagnosis markers is also up for debate. Consistent with other studies’ findings, Mobiluncus was observed in vaginal bacterial communities only in the presence of BV, which was also highly resistant to metronidazole [40,41]. Prevotella (belonging to Bacteroidetes, predominant microbiota in the complex vaginal communities of BV) and Sneathia (belonging to Fusobacteria, a lactic acid-producer) also showed a strong association with BV.
Recent evidence has proved that TV infection is changed by the microbiome of women [42,43] and TV treatment is altered through using the microbiome [44]. The cluster analysis was performed to further visualize the association between TV and the composition of vaginal microbiota. Among vaginal pathogenic bacteria, Anaerococcus, Lysobacter, Mycoplasma, Peptoniphilus, Sneathia, and Prevotella were more ordinary, with higher copy numbers in the TV group (P<0.05). TV has a visually higher average of 14.5% Lactobacillus compared with BV but lower compared with NC. However, the distribution of Anaerococcus, Sneathia, and Prevotella are like the BV microbiota indicating that the two types vaginal infections frequently occur as co-infections among women [45-48]. Mycoplasma is a well-recognized component of bacterial vaginosis microbiota and quantitative Mycoplasma nucleic acid amplification assays are predictive of bacterial vaginosis [49]. According to our data, we would think that Mycoplasma was in high abundance of in TV instead of BV. The heat map from cluster analysis proved that the vaginal flora of TV was characterized by high abundance of Mycoplasma and relatively few Lactobacillus, indicating that TV had a direct impact on the microbial environment and confirmed the potential significance in the interactions between TV and vaginal microbiota. In vitro studies have demonstrated that Mycoplasma is taken up by TV and is able to survive within cytoplasmic vacuoles [50,51]. Moreover, Mycoplasma imposes significant influence on the metabolism of TV [52] and may increase its pathogenicity [53]. Considering the strength of the association between Mycoplasma and TV, the fact is that Mycoplasma is an obligate symbiont. Another organism closely correlated here with TV is Parvimonas, which is a common oral pathogen associated with dental root canal infections [54,55]. Thus, there exist clear differences in the composition of vaginal bacterial communities between TV women and TV-uninfected women.
There is controversy about the effect of vaginal microbiota in VVC in the references. VVC is an ordinary adverse reaction caused by BV treatment with antibiotics, indicating that the vaginal microbiota might be relevant to the yeast colonization [56]. In our studies, two distinct points were found in comparison with other references [57,58]: with a significant high abundance of Lactobacillus, VVC samples presented a few community structures. Two kinds of OTUs, including Aerococcus and Lactobacillus are known to be associated with VVC. The predominant bacterial population in VVC vagina was Lactobacillus at the level of the genus. In comparison, other studies have found that there was abundant Lactobacillus spp. in VVC, presenting a significant difference in the vaginal microbiomes between VVC patients and healthy controls. With the consideration of the depletion of Lactobacillus in BV and TV patients, Candida infection may create a condition that was beneficial to Lactobacillus growth. Our present findings showed the likelihood of symptomatic VVC might be significantly increased when there was a decrease in the diversity of vaginal flora and a concomitant emergence of a lot of lactobacilli. Whether or not lactobacilli increase the risk of VVC [4-59,60] is still in debating.
Conclusion
In summary, our results support that there are more diverse vaginal microbiota in TV or BV participants than we expected before, with a relatively low abundance of Lactobacillus. But to our surprise, the VVC samples present fewer community structure, with a significant high abundance of Lactobacillus. Specifically, the results indicate that there isn’t any decrease in the proportion of lactobacilli in the vaginal communities of women with VVC, suggesting that indigenous vaginal bacterial species like Lactobacillus probably are not crucial factors protecting from Candida infections. Furthermore, there may be a significant increase in the likelihood of symptomatic VVC when the decrease in the diversity of vaginal flora and the concomitant emergence of a lot of lactobacilli. In comparison, our results typically present that Lactobacillus shows a predominance in the vaginal microbiome of healthy women. However, our study still had some limitations. First, it is a cross-sectional study, so longitudinal cohort studies will be required to address the microbiota profile about low genital infection disease. Second, we haven’t explored dynamics of vaginal bacterial communities and its diversity in the reconstruction of vaginal microbiota after effective treatment. It is necessary to further study the interaction between the vaginal microbiota and the host, especially those bacteria found in our study with low abundance, so as to have an extensive understanding of the ecological role of the complex vaginal bacterial communities. To better know of the interactions of host and bacteria in the vagina and make a customized treatment for vaginal infectious diseases, high-throughput sequencing techniques are used to carry out longitudinal samples before and after treatment in further studies.
Acknowledgements
The authors acknowledge the Department of Obstetrics and Gynecology, the First Affiliated Hospital, Baotou Medical College and Digital microbiota technology Co., Ltd. Shenzhen for their cooperation.
Disclosure of conflict of interest
None.
Abbreviations
- BV
Bacterial vaginosis
- VVC
Candida vaginitis
- TV
Trichomonas vaginalis
- NGS
Next-generation sequencing
References
- 1.White BA, Creedon DJ, Nelson KE, Wilson BA. The vaginal microbiome in health and disease. Trends Endocrinol Metab. 2011;22:389–393. doi: 10.1016/j.tem.2011.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4680–4687. doi: 10.1073/pnas.1002611107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Fettweis JM, Serrano MG, Girerd PH, Jefferson KK, Buck GA. A new era of the vaginal microbiome: advances using next-generation sequencing. Chem Biodivers. 2012;9:965–976. doi: 10.1002/cbdv.201100359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180:1863–1868. doi: 10.1086/315127. [DOI] [PubMed] [Google Scholar]
- 5.Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961–1971. doi: 10.1016/S0140-6736(07)60917-9. [DOI] [PubMed] [Google Scholar]
- 6.Peixoto F, Camargos A, Duarte G, Linhares I, Bahamondes L, Petracco A. Efficacy and tolerance of metronidazole and miconazole nitrate in treatment of vaginitis. Int J Gynaecol Obstet. 2008;102:287–292. doi: 10.1016/j.ijgo.2008.04.014. [DOI] [PubMed] [Google Scholar]
- 7.Kalra A, Palcu CT, Sobel JD, Akins RA. Bacterial vaginosis: culture- and PCR-based characterizations of a complex polymicrobial disease’s pathobiology. Curr Infect Dis Rep. 2007;9:485–500. doi: 10.1007/s11908-007-0074-4. [DOI] [PubMed] [Google Scholar]
- 8.Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 national health and nutrition examination survey data. Obstet Gynecol. 2007;109:114–120. doi: 10.1097/01.AOG.0000247627.84791.91. [DOI] [PubMed] [Google Scholar]
- 9.Schwebke JR. New concepts in the etiology of bacterial vaginosis. Curr Infect Dis Rep. 2009;11:143–147. doi: 10.1007/s11908-009-0021-7. [DOI] [PubMed] [Google Scholar]
- 10.Ilkit M, Guzel AB. The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Crit Rev Microbiol. 2011;37:250–261. doi: 10.3109/1040841X.2011.576332. [DOI] [PubMed] [Google Scholar]
- 11.Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med. 1995;333:1737–1742. doi: 10.1056/NEJM199512283332604. [DOI] [PubMed] [Google Scholar]
- 12.Sweet RL. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis. 1995;20(Suppl 2):S271–5. doi: 10.1093/clinids/20.supplement_2.s271. [DOI] [PubMed] [Google Scholar]
- 13.Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG. Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex Transm Dis. 1997;24:353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
- 14.Haggerty CL, Hillier SL, Bass DC, Ness RB PID Evaluation and Clinical Health study investigators. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis. 2004;39:990–995. doi: 10.1086/423963. [DOI] [PubMed] [Google Scholar]
- 15.Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36:663–668. doi: 10.1086/367658. [DOI] [PubMed] [Google Scholar]
- 16.Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005;191:1129–1139. doi: 10.1086/427777. [DOI] [PubMed] [Google Scholar]
- 17.Sobel JD. Pathogenesis of recurrent vulvovaginal candidiasis. Curr Infect Dis Rep. 2002;4:514–519. doi: 10.1007/s11908-002-0038-7. [DOI] [PubMed] [Google Scholar]
- 18.Kaul R, Nagelkerke NJ, Kimani J, Ngugi E, Bwayo JJ, Macdonald KS, Rebbaprgada A, Fonck K, Temmerman M, Ronald AR, Moses S Kibera HIV Study Group. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007;196:1692–1697. doi: 10.1086/522006. [DOI] [PubMed] [Google Scholar]
- 19.Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197:548–554. doi: 10.1086/526496. [DOI] [PubMed] [Google Scholar]
- 20.Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, Schwebke JR. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202:1907–1915. doi: 10.1086/657320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Treangen TJ, Salzberg SL. Repetitive DNA and next-generation sequencing: computational challenges and solutions. Nat Rev Genet. 2012;13:36–46. doi: 10.1038/nrg3117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371–389. doi: 10.1146/annurev-micro-092611-150157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Shokralla S, Spall JL, Gibson JF, Hajibabaei M. Next-generation sequencing technologies for environmental DNA research. Mol Ecol. 2012;21:1794–1805. doi: 10.1111/j.1365-294X.2012.05538.x. [DOI] [PubMed] [Google Scholar]
- 24.Pepin J, Deslandes S, Giroux G, Sobela F, Khonde N, Diakite S, Demeule S, Labbe AC, Carrier N, Frost E. The complex vaginal flora of West African women with bacterial vaginosis. PLoS One. 2011;6:e25082. doi: 10.1371/journal.pone.0025082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, Abdo Z, Forney LJ, Ravel J. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4:132ra152. doi: 10.1126/scitranslmed.3003605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Shipitsyna E, Roos A, Datcu R, Hallén A, Fredlund H, Jensen JS, Engstrand L, Unemo M. Composition of the vaginal microbiota in women of reproductive age - sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One. 2013;8:e60670. doi: 10.1371/journal.pone.0060670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14–22. doi: 10.1016/0002-9343(83)91112-9. [DOI] [PubMed] [Google Scholar]
- 28.Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297–301. doi: 10.1128/jcm.29.2.297-301.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205–211. doi: 10.1136/gut.2005.073817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4516–4522. doi: 10.1073/pnas.1000080107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M, Gormley N, Gilbert JA, Smith G, Knight R. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621–1624. doi: 10.1038/ismej.2012.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336. doi: 10.1038/nmeth.f.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072. doi: 10.1128/AEM.03006-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, Romero R. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011;118:533–549. doi: 10.1111/j.1471-0528.2010.02840.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000;51:349–356. doi: 10.1146/annurev.med.51.1.349. [DOI] [PubMed] [Google Scholar]
- 36.Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69:962–976. [PubMed] [Google Scholar]
- 37.Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353:1899–1911. doi: 10.1056/NEJMoa043802. [DOI] [PubMed] [Google Scholar]
- 38.Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D. Molecular quantification of Gardnerella vaginalis and atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis. 2008;47:33–43. doi: 10.1086/588661. [DOI] [PubMed] [Google Scholar]
- 39.Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y, Xiang C. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics. 2010;11:488. doi: 10.1186/1471-2164-11-488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Nyirjesy P, McIntosh MJ, Steinmetz JI, Schumacher RJ, Joffrion JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis. Sex Transm Dis. 2007;34:197–202. doi: 10.1097/01.olq.0000235152.98601.d7. [DOI] [PubMed] [Google Scholar]
- 41.Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol. 2008;74:4898–4909. doi: 10.1128/AEM.02884-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Martin DH, Zozaya M, Lillis RA, Myers L, Nsuami MJ, Ferris MJ. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis. 2013;207:1922–1931. doi: 10.1093/infdis/jit100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hirt RP, Sherrard J. Trichomonas vaginalis origins, molecular pathobiology and clinical considerations. Curr Opin Infect Dis. 2015;28:72–79. doi: 10.1097/QCO.0000000000000128. [DOI] [PubMed] [Google Scholar]
- 44.Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, Schmidt N, Rosenthal SL, Myers L, Martin DH. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr. 2010;55:565–571. doi: 10.1097/QAI.0b013e3181eda955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Thomason JL, Gelbart SM, Sobun JF, Schulien MB, Hamilton PR. Comparison of four methods to detect trichomonas vaginalis. J Clin Microbiol. 1988;26:1869–1870. doi: 10.1128/jcm.26.9.1869-1870.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Franklin TL, Monif GR. Trichomonas vaginalis and bacterial vaginosis. Coexistence in vaginal wet mount preparations from pregnant women. J Reprod Med. 2000;45:131–134. [PubMed] [Google Scholar]
- 47.Demirezen S, Kaya D, Beksac S. Cytologic findings in pap smears with actinomyces-like organisms. Acta Cytol. 2005;49:257–261. doi: 10.1159/000326146. [DOI] [PubMed] [Google Scholar]
- 48.Heller DS, Maslyak S, Skurnick J. Is the presence of trichomonas on a pap smear associated with an increased incidence of bacterial vaginosis? J Low Genit Tract Dis. 2006;10:137–139. doi: 10.1097/00128360-200607000-00002. [DOI] [PubMed] [Google Scholar]
- 49.Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT. Female genital-tract HIV load correlates inversely with lactobacillus species but positively with bacterial vaginosis and mycoplasma hominis. J Infect Dis. 2005;191:25–32. doi: 10.1086/426394. [DOI] [PubMed] [Google Scholar]
- 50.Dessi D, Delogu G, Emonte E, Catania MR, Fiori PL, Rappelli P. Long-term survival and intracellular replication of mycoplasma hominis in trichomonas vaginalis cells: potential role of the protozoon in transmitting bacterial infection. Infect Immun. 2005;73:1180–1186. doi: 10.1128/IAI.73.2.1180-1186.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Vancini RG, Benchimol M. Entry and intracellular location of Mycoplasma hominis in Trichomonas vaginalis. Arch Microbiol. 2008;189:7–18. doi: 10.1007/s00203-007-0288-8. [DOI] [PubMed] [Google Scholar]
- 52.Morada M, Manzur M, Lam B, Tan C, Tachezy J, Rappelli P, Dessi D, Fiori PL, Yarlett N. Arginine metabolism in Trichomonas vaginalis infected with mycoplasma hominis. Microbiology (Reading) 2010;156:3734–3743. doi: 10.1099/mic.0.042192-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Vancini RG, Pereira-Neves A, Borojevic R, Benchimol M. Trichomonas vaginalis harboring Mycoplasma hominis increases cytopathogenicity in vitro. Eur J Clin Microbiol Infect Dis. 2008;27:259–267. doi: 10.1007/s10096-007-0422-1. [DOI] [PubMed] [Google Scholar]
- 54.Santos AL, Siqueira JF Jr, Rocas IN, Jesus EC, Rosado AS, Tiedje JM. Comparing the bacterial diversity of acute and chronic dental root canal infections. PLoS One. 2011;6:e28088. doi: 10.1371/journal.pone.0028088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Flynn TR, Paster BJ, Stokes LN, Susarla SM, Shanti RM. Molecular methods for diagnosis of odontogenic infections. J Oral Maxillofac Surg. 2012;70:1854–1859. doi: 10.1016/j.joms.2011.09.009. [DOI] [PubMed] [Google Scholar]
- 56.Pirotta MV, Gunn JM, Chondros P. “Not thrush again!” Women’s experience of post-antibiotic vulvovaginitis. Med J Aust. 2003;179:43–46. doi: 10.5694/j.1326-5377.2003.tb05418.x. [DOI] [PubMed] [Google Scholar]
- 57.Liu MB, Xu SR, He Y, Deng GH, Sheng HF, Huang XM, Ouyang CY, Zhou HW. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PLoS One. 2013;8:e79812. doi: 10.1371/journal.pone.0079812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sobel JD, Chaim W. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol. 1996;34:2497–2499. doi: 10.1128/jcm.34.10.2497-2499.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996;174:1058–1063. doi: 10.1093/infdis/174.5.1058. [DOI] [PubMed] [Google Scholar]
- 60.Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol. 2004;104:926–930. doi: 10.1097/01.AOG.0000140687.51048.73. [DOI] [PubMed] [Google Scholar]
